Education
About Us
Working with TipRanks
Follow Us
MacroGenics (MGNX)
NASDAQ:MGNX
Total Valuation
MacroGenics has a market cap or net worth of $190.67M. The enterprise value is $239.32M.
Market Cap$190.67M
Enterprise Value$239.32M
Share Statistics
MacroGenics has 63,555,836 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,555,836
Owned by Insiders11.49%
Owned by Institutions6.00%
Financial Efficiency
MacroGenics’s return on equity (ROE) is -1.34 and return on invested capital (ROIC) is -32.98%.
Return on Equity (ROE)-1.34
Return on Assets (ROA)-0.29
Return on Invested Capital (ROIC)-32.98%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee438.42K
Profits Per Employee-218.83K
Employee Count341
Asset Turnover0.58
Inventory Turnover5.46
Valuation Ratios
The current PE Ratio of MacroGenics is ―. MacroGenics’s PEG ratio is -0.13.
PE Ratio―
PS Ratio0.68
PB Ratio1.83
Price to Fair Value1.83
Price to FCF-1.23
Price to Operating Cash Flow-2.34
PEG Ratio-0.13
Income Statement
In the last 12 months, MacroGenics had revenue of 149.50M and earned -74.62M in profits. Earnings per share was -1.18.
Revenue149.50M
Gross Profit106.32M
Operating Income-72.84M
Pretax Income-75.29M
Net Income-74.62M
EBITDA-65.67M
Earnings Per Share (EPS)-1.18
Cash Flow
In the last 12 months, operating cash flow was -81.04M and capital expenditures -1.91M, giving a free cash flow of -82.95M billion.
Operating Cash Flow-81.04M
Free Cash Flow-82.95M
Free Cash Flow per Share-1.31
Dividends & Yields
MacroGenics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.85
52-Week Price Change35.14%
50-Day Moving Average1.90
200-Day Moving Average1.65
Relative Strength Index (RSI)76.35
Average Volume (3m)711.95K
Important Dates
MacroGenics upcoming earnings date is May 13, 2026, TBA (Confirmed).
Last Earnings DateMar 9, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
MacroGenics as a current ratio of 5.10, with Debt / Equity ratio of 192.05%
Current Ratio5.10
Quick Ratio4.92
Debt to Market Cap0.74
Net Debt to EBITDA-0.75
Interest Coverage Ratio-8.56
Taxes
In the past 12 months, MacroGenics has paid -672.00K in taxes.
Income Tax-672.00K
Effective Tax Rate<0.01
Enterprise Valuation
MacroGenics EV to EBITDA ratio is -2.30, with an EV/FCF ratio of -1.82.
EV to Sales1.01
EV to EBITDA-2.30
EV to Free Cash Flow-1.82
EV to Operating Cash Flow-1.87
Balance Sheet
MacroGenics has $189.91M in cash and marketable securities with $106.76M in debt, giving a net cash position of $83.15M billion.
Cash & Marketable Securities$189.91M
Total Debt$106.76M
Net Cash$83.15M
Net Cash Per Share$1.31
Tangible Book Value Per Share$0.88
Margins
Gross margin is 71.12%, with operating margin of -48.72%, and net profit margin of -49.91%.
Gross Margin71.12%
Operating Margin-48.72%
Pretax Margin-50.36%
Net Profit Margin-49.91%
EBITDA Margin-43.93%
EBIT Margin-48.72%
Analyst Forecast
The average price target for MacroGenics is $4.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.00
Price Target Upside33.33% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast-9.70%
EPS Growth Forecast23.23%